On January 23, 2020, a 61-year-old woman presented with acute asthenia in both sexes and severe fatigue, with a one-day evolution.
He had returned from Wuhan on January 19, but did not report fever, cough, chest pain, or diarrhea.
Its temperature was 36.5 °C, oxygen saturation 99% in room air and respiratory rate 16 r.p.m.
Pulmonary auscultation revealed no abnormalities.
Neurological examination showed symmetric asthenia (grade 4/5 of the Medical Research Council) and areflexia in both feet and feet.
3 days after admission, her symptoms worsened.
Muscle strength was grade 4/5 in both arms and 3/5 in both hands and feet.
The sensitivity to touch and pins decreased distally.
Laboratory tests were clinically significant for▁lymphocytic colitis at admission (0.52 x 109/L; normal range: 1.1-3.2 × 109/L) and thrombocytopenia (113 × 109/L; normal range: 125-300 × 109/L).
CSF tests showed normal numbers of cells (5 x 106/L; normal range: 0-8 × 106/L) and high values of proteins (124 mg/dL; normal range: 8-43 mg/dL).
Nerve conduction tests (day 5) revealed delayed distal latencies and absence of F waves in an early stage, consistent manifestations with demyelinating neuropathy.
She was diagnosed with Guillain-̄s syndrome and received immunoglobulin i.v.
On day 8 (30 January), the patient developed dry cough and fever 38.2 °C.
The chest CT scan showed ground glass opacities in both lungs.
The oropharyngeal swabs were positive for SARS-CoV-2 by RT-PCR test.
Immediately, the patient was referred to an infectious disease ward and symptomatic treatment and antiviral drugs arbidol, lopinavir and ritonavir were administered.
Her clinical condition gradually improved and her lymphocyte and thrombocyte counts returned to normal by day 20.
She was discharged on day 30, with normal muscle strength and recovery of reflexes in both arms and legs.
Her respiratory symptoms also remitted.
Tests with oropharyngeal swabs for SARS-CoV-2 were negative.
